Yellow 6

Yellow 6, officially designated FD&C Yellow No. 6 in the United States and E110 (Sunset Yellow FCF) in the European Union, is a synthetic azo dye widely used to impart an orange-yellow color to processed foods and beverages. It belongs to the monoazo class of synthetic dyes, derived from aromatic sulfonated compounds through a diazo-coupling reaction.

It is one of the most commonly used food colorants globally, appearing in products ranging from soft drinks and snack foods to confectionery, cereals, and pharmaceuticals. Its bright, stable hue and ease of solubility in water make it particularly attractive for beverage and powder applications.

Regulatory agencies worldwide, including the U.S. Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA), have evaluated Yellow 6 and established acceptable daily intake (ADI) levels, permitting its use within defined limits. However, ongoing debate surrounds its potential contribution to hyperactivity in children, based largely on a 2007 study (the McCann study) that prompted European labeling requirements for products containing certain artificial colors including E110.

The overall scientific consensus, as of the most recent reviews, is that Yellow 6 is safe for the general population at typical dietary exposure levels, though some regulatory bodies have applied precautionary measures, particularly for children.

Yellow 6 is a monoazo dye characterised by a single azo linkage (–N=N–) connecting two aromatic ring systems. One end is a sulfonated benzene ring (phenyl ring bearing a sulfonate group, –SO₃Na) that serves as the diazonium component, while the other is a 2-naphthalenesulfonate ring system bearing a hydroxyl group at the 6-position, which acts as the coupling component. The full IUPAC name is disodium 6-hydroxy-5-[(4-sulfonatophenyl)azo]-2-naphthalenesulfonate. The two sulfonate groups (–SO₃⁻) confer water solubility and exist as sodium salts in commercial preparations. The hydroxyl group and the extended conjugated system including the azo bond are primarily responsible for light absorption in the visible orange-yellow region (~480–485 nm). The molecule is planar due to conjugation, which enhances its tinctorial strength.

Yellow 6 is produced industrially via a classical diazotisation-coupling reaction sequence. First, 4-aminobenzenesulfonic acid (sulfanilic acid) is diazotised by treatment with sodium nitrite in the presence of hydrochloric acid at low temperature (0–5 °C), producing the reactive diazonium salt. This intermediate is then coupled with 6-hydroxy-2-naphthalenesulfonic acid (Schaeffer's acid) in mildly alkaline aqueous solution, forming the crude azo dye. The reaction mixture is subsequently salted out using sodium chloride to precipitate the disodium salt, which is filtered, washed, and dried. The commercial product must meet purity specifications set by regulatory agencies: the FDA's specifications (21 CFR 74.706) limit subsidiary dyes, heavy metals, and aromatic amine contaminants. The finished product is a fine reddish-orange powder that disperses to a bright orange-yellow in aqueous solution.

Synthetic azo dyes were first developed in the 1860s following William Henry Perkin's discovery of mauveine in 1856, which opened the era of coal-tar dyes. Sunset Yellow FCF (Yellow 6) was introduced commercially in the early twentieth century, with documented use in foods dating to approximately the 1910s–1920s. In the United States, the Federal Food, Drug, and Cosmetic Act of 1938 and subsequent Color Additive Amendments of 1960 established the framework for certifying color additives, and Yellow 6 received permanent listing as FD&C Yellow No. 6 following safety evaluations. In the European Community, it was assigned E110 during the harmonisation of food additive lists. A pivotal moment in its regulatory history came in 2007 when a Southampton University study (McCann et al.) suggested an association between certain artificial food colors—including Sunset Yellow—and hyperactivity in children, leading the European Food Safety Authority to revisit its evaluation and the European Commission to require warning labels on foods containing these colors. The FDA conducted its own review and concluded in 2011 that a causal link had not been established for the general population, maintaining its approved status.

• Color consistency: Provides a reliable, reproducible orange-yellow hue across production batches, something natural alternatives frequently cannot achieve.
• Heat stability: Withstands the high temperatures of pasteurisation, baking, and retort processing better than many natural colourings.
• Light stability: More resistant to photodegradation than carotenoid-based alternatives in many formulations.
• Water solubility: Dissolves easily in aqueous food systems including beverages, syrups, and gels.
• Cost effectiveness: Significantly less expensive per unit of color than equivalent natural extracts such as annatto or beta-carotene in some applications.
• pH range: Remains stable across the pH range typical of most food and beverage products.
• Consumer appeal: Orange-yellow tones are associated with fruit, citrus, and warmth, supporting product perception and purchase intent.
• Blendability: Can be combined with other certified colors (e.g., Yellow 5, Red 40) to achieve custom shades across the orange-red spectrum.

None established. Yellow 6 is used solely as a colouring agent and confers no nutritional value, bioactive benefit, or established health advantage. It does not contribute calories, vitamins, minerals, or bioactive compounds in amounts relevant to human health. Regulatory evaluations assess it purely on a safety-versus-risk basis, not on the basis of any benefit beyond aesthetic function.

Allergic and Hypersensitivity Reactions (established, but uncommon)

Yellow 6 can provoke urticaria (hives), angioedema, rhinitis, and, in rare cases, anaphylaxis in sensitised individuals. Cross-reactivity with aspirin and other salicylates has been reported in the literature, and individuals with aspirin sensitivity may be at modestly elevated risk. The overall prevalence of true Yellow 6 allergy in the general population is considered low.

Hyperactivity in Children (limited, contested evidence)

The 2007 McCann et al. study published in The Lancet found a statistically significant increase in hyperactive behavior in children consuming a mixture of six artificial colors (including Sunset Yellow) plus sodium benzoate. EFSA reviewed the study and noted methodological limitations but could not exclude a modest effect. The FDA's 2011 review concluded that the evidence did not support a causal link for the general paediatric population. This remains an area of ongoing research. The effect, if real, appears to reflect an additive mixture rather than Yellow 6 alone, and individual susceptibility may vary.

Carcinogenicity (not established in humans)

High-dose animal studies in the 1970s–1980s raised questions about potential carcinogenicity; however, subsequent comprehensive reviews by the FDA, EFSA, and the Joint FAO/WHO Expert Committee on Food Additives (JECFA) have not identified a carcinogenic risk at exposure levels relevant to normal dietary intake. The evidence does not support classifying Yellow 6 as a human carcinogen.

Contaminant concerns (historically established; now managed)

Earlier commercial preparations contained trace levels of aromatic amine contaminants, including beta-naphthylamine, a known carcinogen. Current regulatory specifications strictly limit such impurities, and certified batches are tested to confirm compliance. This risk is therefore managed, not inherent, in properly certified product.

The Joint FAO/WHO Expert Committee on Food Additives (JECFA) has established an acceptable daily intake (ADI) of 0–4 mg/kg body weight per day for Sunset Yellow FCF (Yellow 6). The EU's EFSA affirmed an ADI of 4 mg/kg bw/day in its 2009 re-evaluation. The FDA has not formally set a numerical ADI but permits use under conditions of good manufacturing practice within specified color additive regulations.

For a 70 kg adult, the JECFA ADI corresponds to approximately 280 mg/day, a level that typical dietary exposure in most populations is estimated to be well below. For children, who are lighter and may consume proportionally more brightly coloured foods, exposure modeling in several national surveys has found mean exposures remain below the ADI, though high-end (95th percentile) intakes in some paediatric subgroups may approach or transiently exceed it in certain dietary patterns. No specific ADI modifications for pregnancy have been established; however, pregnant individuals sensitive to azo dyes or with aspirin hypersensitivity may wish to minimize intake as a precaution. There is no established safe intake level for individuals with confirmed allergy; avoidance is recommended for such individuals.

The most cited study linking Yellow 6 to adverse behavioural effects is the McCann et al. (2007) double-blind, randomised, placebo-controlled trial published in The Lancet (doi:10.1016/S0140-6736(07)61306-3), involving 153 three-year-olds and 144 eight/nine-year-olds. The study used two commercial mixtures of artificial colors plus sodium benzoate and found significant increases in hyperactivity scores. However, the study tested mixtures—not individual dyes—making it impossible to attribute effects to Yellow 6 specifically. Critics have also pointed to reliance on teacher and parent ratings rather than objective measures.

EFSA's 2009 opinion on Sunset Yellow FCF (EFSA Journal 2009;7(11):1330) reviewed genotoxicity, carcinogenicity, reproductive toxicity, and behavioural data. EFSA maintained the ADI of 4 mg/kg bw/day but could not exclude a contribution of the Southampton mixture to hyperactivity. The FDA convened a Food Advisory Committee in 2011 that reviewed available evidence and concluded that a causal link between artificial color consumption and hyperactivity in the general paediatric population had not been established, although the committee acknowledged the possibility of a response in a sensitive subgroup.

Genotoxicity studies in bacterial and mammalian systems have generally been negative for Yellow 6. Long-term rodent carcinogenicity bioassays at high doses have not produced findings considered relevant to typical human dietary exposure, according to JECFA and EFSA reviews. Immunotoxicity and allergy data confirm a low but non-zero rate of hypersensitivity reactions. Overall, the body of peer-reviewed evidence does not establish a significant health risk at ADI-compliant exposures, while acknowledging remaining uncertainties around behavioural effects in sensitive children.

Yellow 6 has been the subject of considerable public and media attention, most intensely following the publication of the McCann et al. study in 2007. Advocacy organizations such as the Center for Science in the Public Interest (CSPI) in the United States have called for a ban on artificial food colors including Yellow 6, arguing that the precautionary principle demands removal from children's foods. This view has received extensive mainstream media coverage and contributed to consumer pressure that has led some food manufacturers to voluntarily reformulate products using natural colourants.

A persistent claim circulating on social media and in popular health publications is that Yellow 6 is derived from petroleum and is therefore inherently toxic or carcinogenic. While it is accurate that the starting materials are petrochemically derived aromatic compounds, the inference that the final certified dye is carcinogenic is not supported by the regulatory toxicological record. Equally overstated are claims that Yellow 6 'causes ADHD': the scientific consensus is that, if an effect on behavior exists in a subset of children, it is a transient increase in hyperactivity—not a cause of the clinical disorder ADHD.

On the other side, some industry communications have minimized legitimate uncertainties, particularly around paediatric exposure. The most scientifically defensible position, reflected in EFSA's labeling requirement, is one of informed transparency: the evidence does not justify prohibition, but consumers—especially parents of young children—are entitled to clear information to make their own choices.

The manufacture of Yellow 6 involves sulfonation chemistry and the generation of nitrogen-containing wastewater, which can pose environmental concerns if not properly managed. Azo dyes as a class are associated with environmental persistence and potential toxicity to aquatic organisms at high concentrations; synthetic dyes are among the most visible industrial water pollutants when treatment is inadequate. However, well-regulated manufacturing facilities employ wastewater treatment processes, including biological and chemical degradation methods, to reduce effluent dye concentrations.

Yellow 6 itself, once consumed, is poorly absorbed and largely excreted in urine and faeces, entering the sewage system in trace amounts far below concentrations of ecotoxicological concern. Life-cycle data specific to Yellow 6 in food applications are limited. The shift of some manufacturers toward natural alternatives (e.g., annatto, paprika extract) as consumer demand changes has its own environmental footprint, as natural colourings often require large-scale agricultural production, water use, and extraction processes. A full comparative environmental assessment would need to account for these upstream impacts.

Workers involved in the manufacture and handling of Yellow 6 powder may be exposed via inhalation of fine dye particles or dermal contact. Azo dye dust can cause occupational asthma and contact dermatitis in sensitised workers. Industrial hygiene controls, including enclosed handling systems, local exhaust ventilation, and appropriate personal protective equipment (gloves, masks, eye protection), are recommended in occupational health guidance for dye manufacturing environments. There is no specific published evidence of unique occupational hazards for Yellow 6 beyond those general to synthetic azo dyes. Food-processing workers using pre-dissolved dye solutions face substantially lower exposure than those handling dry powder.

Extensive animal testing has been conducted on Yellow 6, including subchronic and chronic feeding studies in rats and dogs, genotoxicity assays, and reproductive toxicity studies. Two-year rat carcinogenicity studies at high doses (up to 5% of diet) conducted in the 1970s and reviewed by JECFA produced some evidence of adrenal tumours in male rats in one study, but subsequent independent analysis and replication studies did not confirm this finding as compound-related or dose-dependent in a manner indicative of a human carcinogenic risk. JECFA and EFSA both concluded that the findings were not relevant to human health at dietary exposure levels. Reproductive and developmental toxicity studies in rodents did not identify teratogenic or fetotoxic effects at doses below overt maternal toxicity. Genotoxicity testing in bacterial mutagenicity assays (Ames test) and mammalian cell systems has been predominantly negative, supporting the view that Yellow 6 is not genotoxic under standard test conditions.

Human data on Yellow 6 are largely derived from exposure assessment studies, the Southampton behavioural study (which used a mixture), and case reports of allergic reactions. No controlled long-term intervention studies in adult humans have examined hard clinical endpoints such as cancer or metabolic disease. Absorption studies indicate that Yellow 6 is poorly absorbed from the gastrointestinal tract; the small absorbed fraction is metabolised in part by intestinal microbiota and excreted primarily in faeces and urine. Epidemiological studies specifically linking Yellow 6 consumption to cancer, cardiovascular disease, or other chronic conditions in humans have not been published. The behavioural evidence in children (discussed under Scientific Research) is the most substantive area of human data, and it remains limited by the mixture design of the key study. Larger, well-powered, single-dye, double-blind trials in children would be needed to resolve remaining uncertainties; to date, such studies have not been conducted.

In the United States, Yellow 6 must be declared on food labels as 'FD&C Yellow No. 6' in the ingredient list; vague terms such as 'artificial color' are not sufficient for certified colors under 21 CFR 101.22(k). In the European Union, it must be listed as 'Sunset Yellow FCF' and/or 'E110', followed by the mandatory advisory statement: 'may have an adverse effect on activity and attention in children.' In Australia and New Zealand, it is listed as 'Sunset Yellow FCF' or 'Color 110'. In Canada, it appears as 'Sunset Yellow FCF'. Consumers searching labels for Yellow 6 should look for any of these names; the dye does not appear under natural-sounding names, as it must be disclosed as an artificial color in most major jurisdictions. Pharmaceutical products may list it as FD&C Yellow No. 6, Sunset Yellow, or by E number on packaging inserts.

None. Yellow 6 (Sunset Yellow FCF) is a fully synthetic azo dye with no natural food sources. It does not occur in plants, animals, fungi, or microorganisms. It should not be confused with naturally occurring yellow-orange pigments such as beta-carotene (found in carrots and other produce), lutein (found in leafy greens), or annatto-derived bixin (found in achiote seeds), which are entirely different chemical compounds used as natural alternatives in some formulations.